Literature DB >> 16818763

Costimulation via CD55 on human CD4+ T cells mediated by CD97.

Melania Capasso1, Lindy G Durrant, Martin Stacey, Siamon Gordon, Judith Ramage, Ian Spendlove.   

Abstract

Decay-accelerating factor (CD55) is a complement regulatory protein, which is expressed by most cells to protect them from complement-mediated attack. CD55 also binds CD97, an EGF-TM7 receptor constitutively expressed on granulocytes and monocytes and rapidly up-regulated on T and B cells upon activation. Early results suggested that CD55 could further enhance T cell proliferation induced by phorbol ester treatment. The present study demonstrates that coengagement of CD55, using either cross-linking mAbs or its natural ligand CD97, and CD3 results in enhanced proliferation of human peripheral blood CD4(+) T cells, expression of the activation markers CD69 and CD25, and secretion of IL-10 and GM-CSF. Recently, an increase in T cell responsiveness in CD55(-/-) mice was shown to be mediated by a lack of complement regulation. In this study, we show that direct stimulation of CD55 on CD4(+) T cells with CD97 can modulate T cell activation but does not interfere with CD55-mediated complement regulation. Our results support a multifaceted role for CD55 in human T cell activation, constituting a further link between innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818763     DOI: 10.4049/jimmunol.177.2.1070

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.

Authors:  Xiao-long Tang; Ying Wang; Da-li Li; Jian Luo; Ming-yao Liu
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

2.  Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses.

Authors:  Lisa A Mannik; Ian Chin-Yee; Shayan Sharif; Luc Van Kaer; Terry L Delovitch; S M Mansour Haeryfar
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

3.  Modulation of PBMC-decay accelerating factor (PBMC-DAF) and cytokines in rheumatoid arthritis.

Authors:  Roma Pahwa; Uma Kumar; Nibhriti Das
Journal:  Mol Cell Biochem       Date:  2016-02-23       Impact factor: 3.396

Review 4.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

5.  Decay-accelerating factor regulates T-cell immunity in the context of inflammation by influencing costimulatory molecule expression on antigen-presenting cells.

Authors:  Chongyun Fang; Takashi Miwa; Wen-Chao Song
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

6.  Depletion of complement does not impact initiation of xenobiotic-induced autoimmune disease.

Authors:  David M Cauvi; Christopher B Toomey; K Michael Pollard
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

7.  Effects of targeted CD97 immune epitopes small interference RNA on cellular biological behaviors in MDA-MB231 malignant breast cancer cell line.

Authors:  Hua Tian; Yang Chen; Jian-Gang Zhao; Da-Ren Liu; Wei-Hua Gong; Li Chen; Yu-Lian Wu; Jian-An Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

8.  Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms.

Authors:  Takashi Miwa; Michael A Maldonado; Lin Zhou; Koei Yamada; Gary S Gilkeson; Robert A Eisenberg; Wen-Chao Song
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

Review 9.  Complement modulation of T cell immune responses during homeostasis and disease.

Authors:  Elizabeth V Clarke; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

10.  Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production.

Authors:  Peter N Lalli; Michael G Strainic; Feng Lin; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.